Innate Immune Response in Kidney Ischemia/Reperfusion Injury
Standard
Innate Immune Response in Kidney Ischemia/Reperfusion Injury : Potential Target for Therapy. / Kezić, Aleksandra; Stajic, Natasa; Thaiss, Friedrich.
In: J IMMUNOL RES, Vol. 2017, 2017, p. 6305439.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Innate Immune Response in Kidney Ischemia/Reperfusion Injury
T2 - Potential Target for Therapy
AU - Kezić, Aleksandra
AU - Stajic, Natasa
AU - Thaiss, Friedrich
PY - 2017
Y1 - 2017
N2 - Acute kidney injury caused by ischemia and subsequent reperfusion is associated with a high rate of mortality and morbidity. Ischemia/reperfusion injury in kidney transplantation causes delayed graft function and is associated with more frequent episodes of acute rejection and progression to chronic allograft nephropathy. Alloantigen-independent inflammation is an important process, participating in pathogenesis of injurious response, caused by ischemia and reperfusion. This innate immune response is characterized by the activity of classical cells belonging to the immune system, such as neutrophils, macrophages, dendritic cells, lymphocytes, and also tubular epithelial cells and endothelial cells. These immune cells not only participate in inflammation after ischemia exerting detrimental influence but also play a protective role in the healing response from ischemia/reperfusion injury. Delineating of complex mechanisms of their actions could be fruitful in future prevention and treatment of ischemia/reperfusion injury. Among numerous so far conducted experiments, observed immunomodulatory role of adenosine and adenosine receptor agonists in complex interactions of dendritic cells, natural killer T cells, and T regulatory cells is emphasized as promising in the treatment of kidney ischemia/reperfusion injury. Potential pharmacological approaches which decrease NF-κB activity and antagonize mechanisms downstream of activated Toll-like receptors are discussed.
AB - Acute kidney injury caused by ischemia and subsequent reperfusion is associated with a high rate of mortality and morbidity. Ischemia/reperfusion injury in kidney transplantation causes delayed graft function and is associated with more frequent episodes of acute rejection and progression to chronic allograft nephropathy. Alloantigen-independent inflammation is an important process, participating in pathogenesis of injurious response, caused by ischemia and reperfusion. This innate immune response is characterized by the activity of classical cells belonging to the immune system, such as neutrophils, macrophages, dendritic cells, lymphocytes, and also tubular epithelial cells and endothelial cells. These immune cells not only participate in inflammation after ischemia exerting detrimental influence but also play a protective role in the healing response from ischemia/reperfusion injury. Delineating of complex mechanisms of their actions could be fruitful in future prevention and treatment of ischemia/reperfusion injury. Among numerous so far conducted experiments, observed immunomodulatory role of adenosine and adenosine receptor agonists in complex interactions of dendritic cells, natural killer T cells, and T regulatory cells is emphasized as promising in the treatment of kidney ischemia/reperfusion injury. Potential pharmacological approaches which decrease NF-κB activity and antagonize mechanisms downstream of activated Toll-like receptors are discussed.
KW - Acute Kidney Injury
KW - Animals
KW - Humans
KW - Immunity, Innate
KW - Inflammation
KW - Kidney
KW - Kidney Transplantation
KW - Mice
KW - NF-kappa B
KW - Purinergic P1 Receptor Agonists
KW - Reperfusion Injury
KW - Toll-Like Receptors
KW - Journal Article
KW - Review
U2 - 10.1155/2017/6305439
DO - 10.1155/2017/6305439
M3 - SCORING: Review article
C2 - 28676864
VL - 2017
SP - 6305439
JO - J IMMUNOL RES
JF - J IMMUNOL RES
SN - 2314-8861
ER -